These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7420270)

  • 1. Heuristic modeling of drug delivery to malignant brain tumors.
    Levin VA; Patlak CS; Landahl HD
    J Pharmacokinet Biopharm; 1980 Jun; 8(3):257-96. PubMed ID: 7420270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
    Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
    J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor.
    Black KL; Ningaraj NS
    Cancer Control; 2004; 11(3):165-73. PubMed ID: 15153840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Vascular Drug Delivery in Cerebral Cancer.
    Humle N; Johnsen KB; Arendt GA; Nielsen RP; Moos T; Thomsen LB
    Curr Pharm Des; 2016; 22(35):5487-5504. PubMed ID: 27464719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain tumor vessels-a barrier for drug delivery.
    Hempel C; Johnsen KB; Kostrikov S; Hamerlik P; Andresen TL
    Cancer Metastasis Rev; 2020 Sep; 39(3):959-968. PubMed ID: 32488404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-arterial infusions of drugs and hyperosmotic solutions as ways of enhancing CNS chemotherapy.
    Fenstermacher J; Gazendam J
    Cancer Treat Rep; 1981; 65 Suppl 2():27-37. PubMed ID: 7346144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent measurements of blood flow and transcapillary transport in avian sarcoma virus-induced experimental brain tumors: implications for chemotherapy.
    Blasberg R; Molnar P; Groothius D; Patlak C; Owens E; Fenstermacher J
    J Pharmacol Exp Ther; 1984 Dec; 231(3):724-35. PubMed ID: 6094798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors.
    Stewart DJ
    J Neurooncol; 1994; 20(2):121-39. PubMed ID: 7807190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective opening of the blood-tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas.
    Weyerbrock A; Walbridge S; Pluta RM; Saavedra JE; Keefer LK; Oldfield EH
    J Neurosurg; 2003 Oct; 99(4):728-37. PubMed ID: 14567609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy delivery issues in central nervous system malignancy: a reality check.
    Muldoon LL; Soussain C; Jahnke K; Johanson C; Siegal T; Smith QR; Hall WA; Hynynen K; Senter PD; Peereboom DM; Neuwelt EA
    J Clin Oncol; 2007 Jun; 25(16):2295-305. PubMed ID: 17538176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model for drug uptake by brain tumors: effects of osmotic treatment and of diffusion in brain.
    Robinson PJ; Rapoport SI
    J Cereb Blood Flow Metab; 1990 Mar; 10(2):153-61. PubMed ID: 2303532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
    Khaitan D; Reddy PL; Ningaraj N
    Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma.
    Zhang F; Xu CL; Liu CM
    Drug Des Devel Ther; 2015; 9():2089-100. PubMed ID: 25926719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted brain delivery nanoparticles for malignant gliomas.
    Pinto MP; Arce M; Yameen B; Vilos C
    Nanomedicine (Lond); 2017 Jan; 12(1):59-72. PubMed ID: 27876436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood flow and blood-to-tissue transport in 9L gliosarcomas: the role of the brain tumor model in drug delivery research.
    Fross RD; Warnke PC; Groothuis DR
    J Neurooncol; 1991 Dec; 11(3):185-97. PubMed ID: 1823340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors.
    Neuwelt EA; Rapoport SI
    Fed Proc; 1984 Feb; 43(2):214-9. PubMed ID: 6692941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
    Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
    Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The blood-brain/tumor barriers: challenges and chances for malignant gliomas targeted drug delivery.
    Zhan C; Lu W
    Curr Pharm Biotechnol; 2012 Sep; 13(12):2380-7. PubMed ID: 23016643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model.
    Aryal M; Park J; Vykhodtseva N; Zhang YZ; McDannold N
    Phys Med Biol; 2015 Mar; 60(6):2511-27. PubMed ID: 25746014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.